W. Xue

A Validation Study on the Lung Immune Prognostic Index for Prognostic Value in Patients with Locally Advanced Non-Small Cell Lung Cancer.

Jun Liang, Jianyang Wang, Zongmei Zhou, 2021, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Complete response induced by anti–PD‐1‐based immunotherapy with toripalimab in a patient with locally advanced lung adenocarcinoma who failed rapidly after concurrent chemoradiotherapy: A case report

J. Duan, Xin Wang, N. Bi, 2020, Journal of clinical pharmacy and therapeutics.

Comparison of efficacy and safety between simultaneous integrated boost intensity-modulated radiotherapy and conventional intensity-modulated radiotherapy in locally advanced non-small-cell lung cancer: a retrospective study

Jun Liang, Zongmei Zhou, Q. Feng, 2019, Radiation Oncology.

Comparison of efficacy and safety between simultaneous integrated boost intensity-modulated radiotherapy and conventional intensity-modulated radiotherapy in locally advanced non-small-cell lung cancer: a retrospective study

Jun Liang, Zongmei Zhou, Q. Feng, 2019, Radiation oncology.

186P Evaluation of event-free survival as a surrogate for overall survival in early-stage triple-negative breast cancer following neoadjuvant therapy

V. Karantza, A. Haiderali, P. Fasching, 2022, Annals of Oncology.